Trial
NCT02537067
Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Cellontech Co., Ltd.
Collaborators
—
Condition
Defect of Articular Cartilage
Intervention
CHONDRON
Why stopped
The study was terminated early due to company reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-08